Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.1M Buy
658,408
+67,828
+11% +$7.81M 0.32% 60
2026
Q1
$64.8M Buy
590,580
+5,163
+0.9% +$572K 0.32% 61
2025
Q4
$64.6M Buy
585,417
+25,918
+5% +$2.85M 0.34% 56
2025
Q3
$62.4M Sell
559,499
-59,779
-10% -$6.28M 0.4% 48
2025
Q2
$65.4M Buy
619,278
+119,155
+24% +$12.5M 0.5% 36
2025
Q1
$55M Buy
500,123
+82,428
+20% +$8.74M 0.58% 31
2024
Q4
$43.2M Buy
417,695
+156,777
+60% +$17.1M 0.52% 40
2024
Q3
$29.3M Buy
260,918
+123,793
+90% +$12.6M 0.56% 29
2024
Q2
$12.3M Buy
137,125
+117,759
+608% +$10.1M 0.54% 37
2024
Q1
$1.68M Buy
19,366
+10,591
+121% +$868K 0.23% 90
2023
Q4
$730K Buy
+8,775
New +$707K 0.18% 129

Other funds holding AFL

&Partners's AFL Position: Q2 2026 in Review

&Partners increased its Aflac (AFL) stake by 11% in Q2 2026, buying an estimated $7.81M and bringing the position to 658,408 shares worth $77.1M. The position accounts for 0.32% of the portfolio, ranked #60.

&Partners first reported a position in AFL in Q4 2023 and has held it in 11 quarters since. 1,702 funds tracked by Wall St. Rank hold AFL as of Q2 2026.

  • &Partners held 658,408 shares of Aflac worth $77.1M as of Q2 2026.
  • &Partners bought 67,828 Aflac shares in Q2 2026, an estimated $7.81M.
  • Aflac made up 0.32% of &Partners's portfolio in Q2 2026, its #60 holding.
  • &Partners first reported a position in Aflac in Q4 2023 and has held it in 11 quarters since.
  • 1,702 funds tracked by Wall St. Rank held Aflac as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.